LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Article Dans Une Revue Haematologica Année : 2020

LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

Domaines

Hématologie

Dates et versions

hal-03012331 , version 1 (18-11-2020)

Identifiants

Citer

Audrey Belot, Ophélie Gourbeyre, Alexis Fay, Anais Palin, Celine Besson-Fournier, et al.. LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA. Haematologica, 2020, 105 (8), pp.e385-e388. ⟨10.3324/haematol.2019.236133⟩. ⟨hal-03012331⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

More